Craig Baden, MD
Radiation Oncology · Gainesville, GANPI 1144545765
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,528 of the $3,488 with a category attached, or 72.5%. 28 manufacturers reported payments, led by Varian Medical Systems, Inc. at 30.5% of the total. Reporting peaked in 2019 at $751 and has fallen 76.8% since, to $174 in 2025.
Across 85 payments — averaging $41.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Varian Medical Systems, Inc.$1K
- GT Medical Technologies, Inc$379
- Novocure Inc.$363
- Boston Scientific$224
- Sumitomo Pharma America, Inc.$196
- Myovant Sciences Inc.$187
- plus $1K from 22 others
What the payments were for
- Consulting fees$96028%
- Food & beverage$2,52872%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Varian Medical Systems, Inc. | 4 | $1,062 |
| GT Medical Technologies, Inc | 2 | $379 |
| Novocure Inc. | 15 | $363 |
| Boston Scientific | 7 | $224 |
| Sumitomo Pharma America, Inc. | 9 | $196 |
| Myovant Sciences Inc. | 4 | $187 |
| Siemens Medical Solutions USA, Inc. | 2 | $151 |
| AstraZeneca | 5 | $105 |
| Brainlab, Inc. | 2 | $95 |
| Blue Earth Diagnostics | 4 | $93 |
| Bayer | 4 | $91 |
| Pfizer | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 3 | $59 |
| Myriad Genetic Laboratories, Inc. | 3 | $53 |
| Teleflex LLC | 2 | $48 |
| Sanofi | 2 | $42 |
| Amgen | 2 | $32 |
| Kvk-tech, Inc. | 2 | $31 |
| Johnson & Johnson | 1 | $25 |
| Genentech USA, Inc. | 1 | $24 |
| Novartis | 1 | $23 |
| AbbVie | 1 | $22 |
| Merck | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Exelixis Inc. | 1 | $21 |
| Abbott | 1 | $20 |
| Fortovia Therapeutics, Inc. | 1 | $17 |
| Blueprint Medicines Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,488 in reported general payments places this provider in the 85th percentile of 165 radiation oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 203 | $2,683 |
| Oxycodone Hcl | 24 | $197 |
| Triamcinolone Acetonide | 16 | $113 |
| Lorazepam | 11 | $12 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Gainesville
- Geoffrey WeidnerGainesville$4K
- Jack GriffethGainesville$4K
- Brooke LeachmanGainesville$1K
- James TaylorGainesville$1K
- Adnan ElhammaliGainesville$1K
- Kristin HigginsAtlanta$230K
- Walter CurranAtlanta$83K
- Ian CrockerAtlanta$51K
- Sagar PatelAtlanta$32K
- Hui-Kuo ShuAtlanta$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.